Constellation Pharmaceuticals, Inc. Announces Resignation of Emma Reeve as Chief Financial Officer
July 15, 2021 at 09:40 am EDT
As previously disclosed, on June 2, 2021, Constellation Pharmaceuticals, Inc. (Constellation), entered into an Agreement and Plan of Merger with MorphoSys AG (Aktiengesellschaft) (MorphoSys), and MorphoSys Development Inc., an indirect wholly owned subsidiary of MorphoSys (Purchaser). In accordance with the Merger Agreement, at the effective time of the Merger, Emma Reeve resigned as Chief Financial Officer of Constellation.